Scott Stoll and Kenzie Hohman, PharmD, discuss the importance of pharmacy advocacy, from localized efforts to federal movement across the profession.
|Articles|April 15, 2008
New report warns of link between insurance fraud and drug diversion
The Coalition Against Insurance Fraud has issued a report about the harmful effects of insurance fraud and what actions can be taken to prevent it from occurring.
Advertisement
Advertisement
Related to this article
Adults with serious mental illness receive GLP-1 prescriptions at rates similar to or higher than their peers, though schizophrenia continued to lag.
Madeline Sutton, MD, MPH, FACOG, joins to discuss risks of HPV infection among women and how pharmacists can improve outcomes in this area.
In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.
A study found that age and physical comorbidities—not psychiatric diagnosis—were associated with nonpsychotropic polypharmacy.
As pharmacists vocalize their willingness to fill in health care gaps, the integration of public health and emerging pharmacy professionals could be profound.
The expert explains 2025-1016 flu, COVID-19, and RSV vaccine updates from AAP, ACOG, AAFP, and IDSA, and what changing schedules mean for pharmacists.
A persistence of pneumococcal meningitis among adults transformed the disease into a public health concern pharmacists fight on a population-wide scale.
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Expert Discusses Flu and COVID-19 Vaccine Guidance
3
AI, Automation Are Transforming Pharmacies into Proactive Care Hubs
4
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
5